Literature DB >> 19725855

Does oxidative stress modulate left ventricular diastolic function in asymptomatic subjects with hereditary hemochromatosis?

Yukitaka Shizukuda1, Charles D Bolan, Dorothy J Tripodi, Vandana Sachdev, Tammy T Nguyen, Gilberto Botello, Yu-Ying Yau, Stanislav Sidenko, Ernst Inez, Mir I Ali, Myron A Waclawiw, Susan F Leitman, Douglas R Rosing.   

Abstract

BACKGROUND: Little is known about the early mechanisms mediating left ventricular (LV) diastolic dysfunction in patients with hereditary hemochromatosis (HH). However, the increased oxidative stress related to iron overload may be involved in this process, and strain rate (SR), a sensitive echocardiography-derived measure of diastolic function, may detect such changes. AIM: we evaluated the relationship between left ventricular diastolic function measured with tissue Doppler SR and oxidative stress in asymptomatic HH subjects and control normal subjects.
MATERIALS AND METHODS: Ninety-four consecutive visits of 43 HH subjects, age 30-74 (50 +/- 10, mean +/- SD), and 37 consecutive visits of 21 normal volunteers, age 30-63 (48 +/- 8), were evaluated over a 3-year period. SR was obtained from the basal septum in apical four-chamber views. All patients had confirmed C282Y homozygosity, a documented history of iron overload, and were New York Heart Association functional class I. Normal volunteers lacked HFE gene mutations causing HH.
RESULTS: In the HH subjects, the SR demonstrated moderate but significant correlations with biomarkers of oxidative stress; however, no correlations were noted in normal subjects. The biomarkers of iron overload per se did not show significant correlations with the SR.
CONCLUSION: Although our study was limited by the relatively small subject number, these results suggest that a possible role of oxidative stress to affect LV diastolic function in asymptomatic HH subjects and SR imaging may be a sensitive measure to detect that effect.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19725855      PMCID: PMC3397801          DOI: 10.1111/j.1540-8175.2009.00956.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  23 in total

1.  Contribution of reactive oxygen species to the pathogenesis of left ventricular failure in Dahl salt-sensitive hypertensive rats: effects of angiotensin II blockade.

Authors:  Peng Guo; Akira Nishiyama; Matlubur Rahman; Yukiko Nagai; Takahisa Noma; Tsunetatsu Namba; Makoto Ishizawa; Kazushi Murakami; Akira Miyatake; Shoji Kimura; Katsufumi Mizushige; Youichi Abe; Koji Ohmori; Masakazu Kohno
Journal:  J Hypertens       Date:  2006-06       Impact factor: 4.844

2.  Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice.

Authors:  Yukitaka Shizukuda; Satoaki Matoba; Omar Y Mian; Tammy Nguyen; Paul M Hwang
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

3.  Cardiac abnormalities in primary hemochromatosis.

Authors:  A Dabestani; J S Child; J K Perloff; W G Figueroa; H R Schelbert; T R Engel
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

4.  Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria.

Authors:  Gülsen Ozdemir; Meltem Ozden; Hale Maral; Sevinc Kuskay; Pinar Cetinalp; Ilhan Tarkun
Journal:  Ann Clin Biochem       Date:  2005-03       Impact factor: 2.057

5.  Myocardial strain decreases with increasing transmurality of infarction: a Doppler echocardiographic and magnetic resonance correlation study.

Authors:  Vandana Sachdev; Anthony H Aletras; Sriram Padmanabhan; Stanislav Sidenko; Yesoda N Rao; Cynthia L Brenneman; Yukitaka Shizukuda; Glenn R Lie; Pamela S Vincent; Myron A Waclawiw; Andrew E Arai
Journal:  J Am Soc Echocardiogr       Date:  2006-01       Impact factor: 5.251

6.  Left ventricular systolic function during stress echocardiography exercise in subjects with asymptomatic hereditary hemochromatosis.

Authors:  Yukitaka Shizukuda; Charles D Bolan; Dorothy J Tripodi; Yu-Ying Yau; Kevin P Smith; Vandana Sachdev; Charles W Birdsall; Stanislav Sidenko; Myron A Waclawiw; Susan F Leitman; Douglas R Rosing
Journal:  Am J Cardiol       Date:  2006-07-07       Impact factor: 2.778

7.  Detection of early systolic dysfunction with strain rate imaging in a patient with light chain cardiomyopathy.

Authors:  A Niedeggen; O A Breithardt; A Franke
Journal:  Z Kardiol       Date:  2005-02

8.  Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography.

Authors:  Tomoko S Kato; Akiko Noda; Hideo Izawa; Akira Yamada; Koji Obata; Kohzo Nagata; Mitsunori Iwase; Toyoaki Murohara; Mitsuhiro Yokota
Journal:  Circulation       Date:  2004-12-06       Impact factor: 29.690

9.  Idiopathic hemochromatosis, an iron storage disease. A. Iron metabolism in hemochromatosis.

Authors:  S C FINCH; C A FINCH
Journal:  Medicine (Baltimore)       Date:  1955-12       Impact factor: 1.889

10.  The effects of losartan and enalapril therapies on the levels of nitric oxide, malondialdehyde, and glutathione in patients with essential hypertension.

Authors:  Gulzade Donmez; Ulver Derici; Deniz Erbas; Turgay Arinsoy; Ayhan Onk; Sukru Sindel; Enver Hasanoglu
Journal:  Jpn J Physiol       Date:  2002-10
View more
  11 in total

1.  Changes in exercise capacity in subjects with cardiac asymptomatic hereditary hemochromatosis during a follow-up after 5 yrs.

Authors:  Yukitaka Shizukuda; Kevin P Smith; Dorothy J Tripodi; Ross Arena; Yu-Ying Yau; Charles D Bolan; Myron A Waclawiw; Susan F Leitman; Douglas R Rosing
Journal:  Am J Phys Med Rehabil       Date:  2012-05       Impact factor: 2.159

2.  Iron Overload or Oxidative Stress? Insight into a Mechanism of Early Cardiac Manifestations of Asymptomatic Hereditary Hemochromatosis Subjects with C282Y Homozygosity.

Authors:  Yukitaka Shizukuda; Dorothy J Tripodi; Douglas R Rosing
Journal:  J Cardiovasc Transl Res       Date:  2016-06-08       Impact factor: 4.132

3.  Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging.

Authors:  Hanrui Zhang; Brandon Morgan; Barry J Potter; Lixin Ma; Kevin C Dellsperger; Zoltan Ungvari; Cuihua Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-30       Impact factor: 4.733

Review 4.  Mechanisms, diagnosis, and treatment of heart failure with preserved ejection fraction and diastolic dysfunction.

Authors:  Gilman D Plitt; Jordan T Spring; Michael J Moulton; Devendra K Agrawal
Journal:  Expert Rev Cardiovasc Ther       Date:  2018-07-16

Review 5.  Advancement of echocardiography for surveillance of iron overload cardiomyopathy: comparison to cardiac magnetic resonance imaging.

Authors:  M Jason Zimmerman; Douglas R Rosing; Yukitaka Shizukuda
Journal:  J Echocardiogr       Date:  2021-03-26

6.  Oxidative stress and cardiac dysfunction in children with chronic renal failure on regular hemodialysis.

Authors:  Mohammed Al-Biltagi; Osama A Tolba; Maher Ahmed Abd ElHafez; Ahmed Abd ElBasset Abo-Elezz; Eman Kamel El Kady; Sahar Mohey El-Din Hazza
Journal:  Pediatr Nephrol       Date:  2016-03-18       Impact factor: 3.714

Review 7.  Iron overload and arrhythmias: Influence of confounding factors.

Authors:  Yukitaka Shizukuda; Douglas R Rosing
Journal:  J Arrhythm       Date:  2019-06-20

Review 8.  The Importance of Multimodality Imaging in the Diagnosis and Management of Patients with Infiltrative Cardiomyopathies: An Update.

Authors:  Radu Sascău; Larisa Anghel; Alexandra Clement; Mădălina Bostan; Rodica Radu; Cristian Stătescu
Journal:  Diagnostics (Basel)       Date:  2021-02-07

9.  Oxidative Stress State Is Associated with Left Ventricular Mechanics Changes, Measured by Speckle Tracking in Essential Hypertensive Patients.

Authors:  Luis Antonio Moreno-Ruíz; David Ibarra-Quevedo; Erika Rodríguez-Martínez; Perla D Maldonado; Benito Sarabia-Ortega; José Gustavo Hernández-Martínez; Beda Espinosa-Caleti; Beatriz Mendoza-Pérez; Selva Rivas-Arancibia
Journal:  Oxid Med Cell Longev       Date:  2015-10-04       Impact factor: 6.543

10.  Personalized medicine in human space flight: using Omics based analyses to develop individualized countermeasures that enhance astronaut safety and performance.

Authors:  Michael A Schmidt; Thomas J Goodwin
Journal:  Metabolomics       Date:  2013-06-27       Impact factor: 4.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.